Application of accelerated mass spectrometry (AMS) in DNA adduct quantification and identification

Ken W Turteltaub, Karen H. Dingley

Research output: Contribution to journalArticle

37 Scopus citations

Abstract

DNA adducts are nucleotide bases that have been covalently modified by reactive electrophilic chemical intermediates, and have been extensively researched for their role in mutagenesis and carcinogenesis. However, many DNA adduct measurement techniques have difficulty in the quantification of adducts at realistic human exposure levels. We are using the extremely sensitive analytical technique of accelerator mass spectrometry (AMS) to study adducts either at low dose or directly in humans. AMS is a technique for measuring isotope ratios with high selectivity, attomole sensitivity (10-18 mol) and precision of 0.5-10%, depending on isotope level and preparation method. This sensitivity and precision is being used to study the dose-response, toxicokinetics, and toxicodynamics of DNA adduct formation and removal following administration of very low doses of chemicals. Copyright (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.

Original languageEnglish (US)
Pages (from-to)435-439
Number of pages5
JournalToxicology Letters
Volume102-103
DOIs
StatePublished - Dec 28 1998
Externally publishedYes

    Fingerprint

Keywords

  • 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline
  • Accelerator mass spectrometry
  • DNA adduct
  • Low level dosimetry

ASJC Scopus subject areas

  • Toxicology

Cite this